|

SR-8541A Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Balstilimab, Botensilimab

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Stingray Therapeutics2

Indications

  • Cancer2
  • Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)1
  • Advanced / Metastatic Solid Tumor1

Other1 trial

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
Phase 1

Morristown, New Jersey1 trial

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Atlantic Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.